Human cytomegalovirus induces multiple means to combat reactive oxygen species

Journal of Virology

Volumn 85, Issue 23, 2011, Pages 12585-12593

  Tilton, Carisa ^a,b   Clippinger, Amy J ^a   Maguire, Tobi ^a   Alwine, James C ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEN PEROXIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; RAPTOR PROTEIN; REACTIVE OXYGEN METABOLITE; SERINE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL PROTECTION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

AMP-ACTIVATED PROTEIN KINASES; ANTIOXIDANTS; BLOTTING, WESTERN; CELLS, CULTURED; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FIBROBLASTS; FORESKIN; GLUTATHIONE; HUMANS; HYDROGEN PEROXIDE; MALE; OXIDANTS; PHOSPHORYLATION; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

HUMAN HERPESVIRUS 5; MAMMALIA; RAPTORES;

EID: 81255200303     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05572-11     Document Type: Article

References (56)

1. Alessi, D. R., L. R. Pearce, and J. M. García-Martínez. 2009. New Insights into mTOR signaling: mTORC2 and beyond. Sci. Signal. 2:pe27.
2. Alwine, J. C. 2008. Modulation of host cell stress responses by human cytomegalovirus. Curr. Top. Microbiol. Immunol. 325:263-279.
3. Astrinidis, A., and E. P. Henske. 2005. Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease. Oncogene 24: 7475-7481.
4. Bailey, H. H. 1998. L-S,R-Buthionine sulfoximine: historical development and clinical issues. Chem. Biol. Interact 111-112:239-254.
5. Bresnahan, W. A., G. E. Hultman, and T. Shenk. 2000. Replication of wild-type and mutant human cytomegalovirus in life-extended human diploid fibroblasts. J. Virol. 74:10816-10818.
6. Buchkovich, N. J., T. G. Maguire, A. W. Paton, J. C. Paton, and J. C. Alwine. 2008. Human cytomegalovirus specifically controls the levels of the endoplasmic reticulum chaperone BiP/GRP78, which is required for virion assembly. J. Virol. 82:31-39.
7. Buchkovich, N. J., Y. Yu, C. A. Zampieri, and J. C. Alwine. 2008. The TORrid affairs of viruses: effects of mammalian DNA viruses on the PI3KAkt-mTOR signaling pathway. Nat. Rev. Microbiol. 6:265-275.
8. Chambers, J. W., T. G. Maguire, and J. C. Alwine. 2010. Glutamine metabolism is essential for human cytomegalovirus infection. J. Virol. 84:1867-1873.
9. Chiang, G. G., and R. T. Abraham. 2005. Phosphorylation of mammalian target of rapamycin (mTOR) at Ser-2448 is mediated by p70S6 kinase. J. Biol. Chem. 280:25485-25490.
10. Child, S. J., M. Hakki, K. L. De Niro, and A. P. Geballe. 2004. Evasion of cellular antiviral responses by human cytomegalovirus TRS1 and IRS1. J. Virol. 78:197-205.
11. Circu, M. L., and T. Aw. 2010. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic. Biol. Med. 48:749-762.
12. Clippinger, A. J., T. G. Maguire, and J. C. Alwine. 2011. The changing role of mTOR kinase in the maintenance of protein synthesis during human cytomegalovirus infection. J. Virol. 85:3930-3939.
13. Clippinger, A. J., T. G. Maguire, and J. C. Alwine. 2011. Human cytomegalovirus infection maintains mTOR activity and its perinuclear localization during amino acid deprivation. J. Virol. 85:9369-9376.
14. Copp, J., G. Manning, and T. Hunter. 2009. TORC-specific phosphorylation of mammalian target of rapamycin (mTOR): phospho-Ser 2481 is a marker for intact mTOR signaling complex 2. Cancer Res. 69:1821-1827.
15. Cullinan, S. B., and J. A. Diehl. 2006. Coordination of ER and oxidative stress signaling: the PERK/Nrf2 signaling pathway. Int. J. Biochem. Cell Biol. 38:317-332.
16. Cullinan, S. B., et al. 2003. Identification of Nrf2 as a novel PERK substrate and critical effector of PERK-dependent cell survival. Mol. Cell. Biol. 23: 7198-7209.
17. Estrela, J. M., A. Ortega, and E. Obrador. 2006. Glutathione in cancer biology and therapy. Crit. Rev. Clin. Lab. Sci. 43:143-181.
18. Finkel, T. 2003. Oxidant signals and oxidative stress. Curr. Opin. Cell Biol. 15:247-254.
19. Finkel, T., and N. J. Holbrook. 2000. Oxidants, oxidative stress and the biology of ageing. Nature 408:239-247.
20. Go, Y. M., and D. P. Jones. 2008. Redox compartmentalization in eukaryotic cells. Biochim. Biophys. Acta 1780:1273-1290.
21. Go, Y. M., and D. P. Jones. 2010. Redox control systems in the nucleus: mechanisms and functions. Antioxid. Redox Signal. 13:489-509.
22. Gwinn, D. M., et al. 2008. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol. Cell 30:214-226.
23. Hakki, M., E. E. Marshall, K. L. De Niro, and A. P. Geballe. 2006. Binding and nuclear relocalization of protein kinase R by human cytomegalovirus TRS1. J. Virol. 80:11817-11826.
24. Harel, N. Y., and J. C. Alwine. 1998. Phosphorylation of the human cytomegalovirus 86-kilodalton immediate-early protein IE2. J. Virol. 72:5481-5492.
25. Huang, C.-F., et al. 2000. Antagonism between members of the CNC-bZIP family and the immediate-early protein IE2 of human cytomegalovirus. J. Biol. Chem. 275:12313-12320.
26. Isler, J. A., T. G. Maguire, and J. C. Alwine. 2005. Production of infectious HCMV virions is inhibited by drugs that disrupt calcium homeostasis in the endoplasmic reticulum. J. Virol. 79:15338-15397.
27. Isler, J. A., A. H. Skalet, and J. C. Alwine. 2005. Human cytomegalovirus infection activates and regulates the unfolded protein response. J. Virol. 79:6890-6899.
28. Itoh, K., T. Ishii, N. Wakabayashi, and M. Yamamoto. 1999. Regulatory mechanisms of cellular response to oxidative stress. Free Radic. Res. 31: 319-324.
29. Jacinto, E., et al. 2004. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat. Cell Biol. 6:1122-1128.
30. Kim, D. H., et al. 2002. mTOR interacts with raptor to form a nutrientsensitive complex that signals to the cell growth machinery. Cell 110:163-175.
31. Kudchodkar, S., Y. Yu, T. Maguire, and J. C. Alwine. 2004. Human cytomegalovirus infection induces rapamycin insensitive phosphorylation of downstream effectors of mTOR kinase. J. Virol. 78:11030-11039.
32. Kudchodkar, S. B., G. Q. Del Prete, T. G. Maguire, and J. C. Alwine. 2007. AMPK-mediated inhibition of mTOR kinase is circumvented during immediate-early times of human cytomegalovirus infection. J. Virol. 81:3649-3651.
33. Kudchodkar, S. B., Y. Yu, T. G. Maguire, and J. C. Alwine. 2006. Human cytomegalovirus infection alters the substrate specificities and rapamycin sensitivities of raptor- and rictor-containing complexes. Proc. Natl. Acad. Sci. U. S. A. 103:14182-14187.
34. Liu, L., D. R. Wise, J. A. Diehl, and M. C. Simon. 2008. Hypoxic reactive oxygen species regulate the integrated stress response and cell survival. J. Biol. Chem. 283:31153-31162.
35. Long, X., Y. Lin, S. Ortiz-Vega, K. Yonezawa, and J. Avruch. 2005. Rheb binds and regulates the mTOR kinase. Curr. Biol. 15:702-713.
36. Long, X., S. Ortiz-Vega, Y. Lin, and J. Avruch. 2005. Rheb binding to mammalian target of rapamycin (mTOR) is regulated by amino acid sufficiency. J. Biol. Chem. 280:23433-23436.
37. Mamane, Y., E. Petroulakis, O. LeBacquer, and N. Sonenberg. 2006. mTOR, translation initiation and cancer. Oncogene 25:6416-6422.
38. Mohr, I. 2006. Phosphorylation and dephosphorylation events that regulate viral mRNA translation. Virus Res. 119:89-99.
39. Moorman, N. J., et al. 2008. Human cytomegalovirus protein UL38 inhibits host cell stress responses by antagonizing the tuberous sclerosis protein complex. Cell Host Microbe 3:1-10.
40. Munger, J., S. U. Bajad, H. A. Coller, T. Shenk, and J. D. Rabinowitz. 2006. Dynamics of the cellular metabolome during human cytomegalovirus infection. PLoS Pathog. 2:1165-1175.
41. Munger, J., et al. 2008. Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy. Nat. Biotechnol. 26:1179-1186.
42. Murphy, E., I. Rigoutsos, T. Shibuya, and T. E. Shenk. 2003. Reevaluation of human cytomegalovirus coding potential. Proc. Natl. Acad. Sci. U. S. A. 100:13585-13590.
43. Murphy, E., et al. 2003. Coding potential of laboratory and clinical strains of human cytomegalovirus. Proc. Natl. Acad. Sci. U. S. A. 25:14976-14981.
44. Nave, B. T., D. M. Ouwens, D. J. Withers, D. R. Alessi, and P. R. Shepherd. 1999. Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation. Biochem. J. 344:427-431.
45. Nguyen, T., P. Sherratt, and C. Pickett. 2003. Regulatory mechanisms controlling gene expression mediated by the antioxidant response element. Annu. Rev. Pharmacol. Toxicol. 43:233-260.
46. Reiling, J. H., and D. M. Sabatini. 2006. Stress and mTORture signaling. Oncogene 25:6373-6383.
47. Rosner, M., N. Siegel, A. Valli, C. Fuchs, and M. Hengstschlager. 2010. mTOR phosphorylated at S2448 binds to raptor and rictor. Amino Acids 38:223-228.
48. Sarbassov, D. D., et al. 2004. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr. Biol. 14:1296-1302.
49. Sarbassov, D. D., S. M. Ali, and D. M. Sabatini. 2005. Growing roles for the mTOR pathway. Curr. Opin. Cell Biol. 17:596-603.
50. Sekulic, A., et al. 2000. A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells. Cancer Res. 60:3504-3513.
51. Speir, E., T. Shibutani, Z. X. Yu, V. Ferrans, and S. E. Epstein. 1996. Role of reactive oxygen intermediates in cytomegalovirus gene expression and in the response of human smooth muscle cells to viral infection. Circ. Res. 79:1143-1152.
52. Walsh, D., C. Perez, J. Notary, and I. Mohr. 2005. Regulation of the translation initiation factor eIF4F by multiple mechanisms in human cytomegalovirus-infected cells. J. Virol. 79:8057-8064.
53. Xuan, B., Z. Qian, E. Torigoi, and D. Yu. 2009. Human cytomegalovirus protein pUL38 induces ATF4 expression, inhibits persistent JNK phosphorylation, and suppresses endoplasmic reticulum stress-induced cell death. J. Virol. 83:3463-3474.
54. Yu, Y., and J. C. Alwine. 2002. Human cytomegalovirus major immediateearly proteins and simian virus 40 large T antigen can inhibit apoptosis through activation of the phosphatidylinositide 3'-OH kinase pathway and cellular kinase Akt. J. Virol. 76:3731-3738.
55. Yu, Y., and J. C. Alwine. 2008. Interaction between simian virus 40 large T antigen and insulin receptor substrate 1 is disrupted by the K1 mutation, resulting in the loss of large T antigen-mediated phosphorylation of Akt. J. Virol. 82:4521-4526.
56. Zhang, Q., J. Pi, C. G. Woods, and M. E. Andersen. 2010. A systems biology perspective on Nrf2-mediated antioxidant response. Toxicol. Appl. Pharmacol. 244:84-97.